Accessibility Menu
 
NovAccess Global logo

NovAccess Global

(OTC) XSNX

Current Price$0.00
Market Cap$6,200
Since IPO (1998)-100%
5 Year-100%
1 Year-50%
1 Month+0%

NovAccess Global Financials at a Glance

Market Cap

$6,200

Revenue (TTM)

$0.00

Net Income (TTM)

$1.89M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-8.45 (Low)

Price

$0.00

Volume

77

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.05

XSNX News

No articles available.

XSNX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NovAccess Global

Industry

Biotechnology

Employees

2

CEO

Dwain Morris-Irvin, PhD

Headquarters

Chesterland, OH 44026, US

XSNX Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

32%

Return on Assets

-77%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.20K

Shares Outstanding

61.65M

Volume

77

Short Interest

0.00%

Avg. Volume

710.246

Financials (TTM)

Gross Profit

$0.00

Operating Income

$2.47M

EBITDA

$1.03M

Operating Cash Flow

$624.64K

Capital Expenditure

$4.00

Free Cash Flow

$624.64K

Cash & ST Invst.

$21.41K

Total Debt

$2.20M

NovAccess Global Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$6.20K

N/A

Market Cap/Employee

$2.07K

N/A

Employees

3

N/A

Net Income

$936.33K

-20.1%

EBITDA

$435.26K

-558125.6%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Net Cash

$2.09M

-13.4%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$2.09M

+9.8%

Return on Assets

-76.62%

N/A

Return on Invested Capital

31.63%

N/A

Free Cash Flow

$58.87K

+48.0%

Operating Cash Flow

$58.87K

+48.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ARDSAridis Pharmaceuticals, Inc.
$0.00+0.00%
EVLOEvelo Biosciences, Inc.
$0.00+0.00%
TRVNTrevena, Inc.
$0.01+0.00%
HLTTHealthtech Solutions Inc.
$0.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CMCSAComcast
$29.02+0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
RITMRithm Capital
$8.77-0.03%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%

Questions About XSNX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.